These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1375968)

  • 21. Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment.
    Fisher MC; LiPuma JJ; Dasen SE; Caputo GC; Mortensen JE; McGowan KL; Stull TL
    J Pediatr; 1993 Nov; 123(5):745-7. PubMed ID: 7693902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review?
    Høiby N; Johansen HK
    J Hosp Infect; 2007 Apr; 65(4):374-5; author reply 375-6. PubMed ID: 17275952
    [No Abstract]   [Full Text] [Related]  

  • 23. Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis.
    Geddes DM
    Lancet; 2001 Aug; 358(9281):522-3. PubMed ID: 11520516
    [No Abstract]   [Full Text] [Related]  

  • 24. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis.
    Thomassen MJ; Demko CA; Doershuk CF; Stern RC; Klinger JD
    Am Rev Respir Dis; 1986 Oct; 134(4):669-71. PubMed ID: 3767122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis.
    Humphreys H; Peckham D; Patel P; Knox A
    Thorax; 1994 Nov; 49(11):1157-9. PubMed ID: 7530384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burkholderia cepacia in cystic fibrosis.
    LiPuma JJ; Stull TL
    N Engl J Med; 1995 Mar; 332(12):820; author reply 820-1. PubMed ID: 7532286
    [No Abstract]   [Full Text] [Related]  

  • 27. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis.
    Lipuma JJ; Marks-Austin KA; Holsclaw DS; Winnie GB; Gilligan PH; Stull TL
    Pediatr Infect Dis J; 1994 Aug; 13(8):716-9. PubMed ID: 7526328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis.
    Burdge DR; Nakielna EM; Noble MA
    Infect Control Hosp Epidemiol; 1993 Mar; 14(3):127-30. PubMed ID: 7683031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of Pseudomonas cepacia in cystic fibrosis patient.
    Marques Ede A; Pinto RM; Dallallana LT; de Oliveira EF; Suassuna I
    Mem Inst Oswaldo Cruz; 1993; 88(1):125-9. PubMed ID: 7504157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis.
    Pegues DA; Schidlow DV; Tablan OC; Carson LA; Clark NC; Jarvis WR
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):805-12. PubMed ID: 7519103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cystic fibrosis and Burkholderia (formerly Pseudomonas) cepacia: an increasing clinical and psychosocial problem].
    Horrevorts AM; Heijerman HG; Möller AV; Dankert-Roelse JE; Mouton JW; van der Laag J; Dankert J
    Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2343-6. PubMed ID: 7501071
    [No Abstract]   [Full Text] [Related]  

  • 34. Pseudomonas cepacia of the temporal bone: malignant external otitis in a patient with cystic fibrosis.
    Dettelbach MA; Hirsch BE; Weissman JL
    Otolaryngol Head Neck Surg; 1994 Oct; 111(4):528-32. PubMed ID: 7524007
    [No Abstract]   [Full Text] [Related]  

  • 35. Nosocomial Acquisition of Burkholderia gladioli in patients with cystic fibrosis.
    Clode FE; Metherell LA; Pitt TL
    Am J Respir Crit Care Med; 1999 Jul; 160(1):374-5. PubMed ID: 10390428
    [No Abstract]   [Full Text] [Related]  

  • 36. A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa.
    Festini F; Taccetti G; Galici V; Neri S; Bisogni S; Ciofi D; Braggion C
    Am J Infect Control; 2010 Apr; 38(3):244-5. PubMed ID: 20129701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.
    Smith DL; Gumery LB; Smith EG; Stableforth DE; Kaufmann ME; Pitt TL
    J Clin Microbiol; 1993 Nov; 31(11):3017-22. PubMed ID: 7505294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia.
    Egan JJ; McNeil K; Bookless B; Gould K; Corris P; Higenbottam T; Webb AK; Woodcock AA
    Lancet; 1994 Aug; 344(8921):552-3. PubMed ID: 7520109
    [No Abstract]   [Full Text] [Related]  

  • 39. Virulence factors of Burkholderia cepacia.
    Nelson JW; Butler SL; Krieg D; Govan JR
    FEMS Immunol Med Microbiol; 1994 Feb; 8(2):89-97. PubMed ID: 7513590
    [No Abstract]   [Full Text] [Related]  

  • 40. Cystic fibrosis camps.
    Speert DP; LiPuma J; Ogle JW
    Pediatr Infect Dis J; 1993 Sep; 12(9):789. PubMed ID: 7692380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.